{
  "timestamp": "2025-04-19 14:56:50",
  "phase": "Evolution",
  "round": 4,
  "elo_score": null,
  "content": "Personalized neoantigen vaccines administered post-resection in early-stage cancer will prevent recurrence by enhancing anti-tumor immunity [Artandi 2010]; [McGranahan 2016]; [Chabanon 2021].  \n*New support:* [Ott 2020, Nature].\n\n---"
}